Terms: = Head and neck cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF
3252 results:
1. N0 neck trial: Does intensification of follow-up (Ultrasound + Physical Examination) influence outcomes in early-stage oral cancer?
Vaish R; Hawaldar R; Gupta S; Dandekar M; Shah S; Chaukar D; Pantvaidya G; Deshmukh A; Chaturvedi P; Pai P; Nair D; Nair S; Thakur M; Ghosh-Laskar S; Agarwal JP; D'Cruz AK
Eur J Cancer; 2024 Jun; 204():114064. PubMed ID: 38705028
[TBL] [Abstract] [Full Text] [Related]
2. Persistent hypercalcaemia associated with two pathogenic variants in the
Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
[TBL] [Abstract] [Full Text] [Related]
3. To what extent can mastication functionality be restored following mandibular reconstruction surgery? A computer modeling approach.
Aftabi H; Sagl B; Lloyd JE; Prisman E; Hodgson A; Fels S
Comput Methods Programs Biomed; 2024 Jun; 250():108174. PubMed ID: 38640839
[TBL] [Abstract] [Full Text] [Related]
4. The potential roles of antibody-drug conjugates in head and neck squamous cell carcinoma.
Filippini DM; Le Tourneau C
Curr Opin Oncol; 2024 May; 36(3):147-154. PubMed ID: 38573203
[TBL] [Abstract] [Full Text] [Related]
5. Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer.
Zhao Y; Wucherpfennig KW
Curr Opin Oncol; 2024 May; 36(3):136-142. PubMed ID: 38573202
[TBL] [Abstract] [Full Text] [Related]
6. head and neck cancer patients treated with concomitant chemoradiotherapy involving the oral cavity and oropharynx: is another choice possible than prophylactic gastrostomy?
Senesse P; Briant J; Boisselier P; Bensadoun RJ; Vinches M; Faravel K
Curr Opin Oncol; 2024 May; 36(3):128-135. PubMed ID: 38573201
[TBL] [Abstract] [Full Text] [Related]
7. Assessing malnutrition in patients with nasopharyngeal carcinoma: Diagnostic protocol for the development and validation of a new nutritional assessment tool.
Wang P; Soh KL; Japar SB; Khazaai HB; Liao J; Ying Y; Ning C; Xue L; Pan X
PLoS One; 2024; 19(3):e0300067. PubMed ID: 38527072
[TBL] [Abstract] [Full Text] [Related]
8. head and neck Mucosal Melanoma: Where Are We Now?
Hanba C; Hanna E
Curr Oncol Rep; 2024 Apr; 26(4):421-425. PubMed ID: 38512416
[TBL] [Abstract] [Full Text] [Related]
9. Advances in testing for human papillomavirus -mediated head and neck cancer.
Mehanna H; Alemany L; von Buchwald C
Curr Opin Oncol; 2024 May; 36(3):143-146. PubMed ID: 38506408
[TBL] [Abstract] [Full Text] [Related]
10. Central nervous system adverse events of immune checkpoint inhibitors.
Farina A; Villagrán-García M; Vogrig A; Joubert B
Curr Opin Neurol; 2024 Jun; 37(3):345-352. PubMed ID: 38483130
[TBL] [Abstract] [Full Text] [Related]
11. Molecular and nutritional markers in head and neck cancer.
Milano G; Gal J; Bensadoun RJ
Curr Opin Oncol; 2024 May; 36(3):123-127. PubMed ID: 38441194
[TBL] [Abstract] [Full Text] [Related]
12. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: Ixeris sonchifolia Induces Hepatocellular Carcinoma Apoptosis via the PI3K/AKT Pathway.
Liu BJ; Guan YY; Qiao LX; Zhang JM; Li AJ; Yang PX; Gao YX; Chen DX; Wang CX; Wu J
J Ethnopharmacol; 2024 Jun; 327():117994. PubMed ID: 38437889
[TBL] [Abstract] [Full Text] [Related]
13. Managing lymphoedema following treatment for head and neck cancer: is complete decongestive therapy an effective intervention to improve dysphagia outcomes?
Smith A
Curr Opin Otolaryngol Head Neck Surg; 2024 Jun; 32(3):178-185. PubMed ID: 38393685
[TBL] [Abstract] [Full Text] [Related]
14. Oral Health in Patients with History of head and neck cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway.
Florimond M; Duong LT; Lours E; Brau JJ; Ferré FC; Fouilloux I; Boukpessi T
Curr Oncol Rep; 2024 Mar; 26(3):258-271. PubMed ID: 38376626
[TBL] [Abstract] [Full Text] [Related]
15. Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors.
Hoch CC; Knoedler L; Knoedler S; Bashiri Dezfouli A; Schmidl B; Trill A; Douglas JE; Adappa ND; Stögbauer F; Wollenberg B
Curr Oncol Rep; 2024 Mar; 26(3):272-291. PubMed ID: 38376625
[TBL] [Abstract] [Full Text] [Related]
16. Anlotinib suppressed tumor cell proliferation and migration in hypopharyngeal carcinoma.
Song H; Song Q; Zhao X; Yang Y; Mou Y; Li Y; Song X
Braz J Otorhinolaryngol; 2024; 90(2):101397. PubMed ID: 38330738
[TBL] [Abstract] [Full Text] [Related]
17. Characterization of a Diverse Set of Conditionally Reprogrammed head and neck cancer Cell Cultures.
Ow TJ; Mehta V; Li D; Thomas C; Shrivastava N; Kawachi N; Gersten AJ; Zhu J; Schiff BA; Smith RV; Rosenblatt G; Augustine S; Prystowsky MB; Yin S; Gavathiotis E; Guha C
Laryngoscope; 2024 Jun; 134(6):2748-2756. PubMed ID: 38288866
[TBL] [Abstract] [Full Text] [Related]
18. The added value of radiomics in determining patient responsiveness to laryngeal preservation strategies.
Ravanelli M; Rondi P; Di Meo N; Farina D
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):134-137. PubMed ID: 38259164
[TBL] [Abstract] [Full Text] [Related]
19. Molecular Genetics Augment Cytopathologic Evaluation and Surgical Planning of Pediatric Thyroid Nodules.
Spaulding SL; Maayah M; Dinauer CA; Prasad M; Darbinyan A; Morotti R; Christison-Lagay ER
J Pediatr Surg; 2024 May; 59(5):975-980. PubMed ID: 38246817
[TBL] [Abstract] [Full Text] [Related]
20. Real-World Outcomes of Inoperable and Metastatic Cutaneous head and neck Melanoma Patients.
Rozendorn N; Shutan I; Feinmesser G; Grynberg S; Hodadov H; Alon E; Asher N
Laryngoscope; 2024 Jun; 134(6):2762-2770. PubMed ID: 38230960
[TBL] [Abstract] [Full Text] [Related]
[Next]
